No UMFA accumulation. Bypasses MTHFR. Does not mask B12 deficiency like folic acid. Same drug interaction with methotrexate. Generally superior and safer than folic acid, particularly for MTHFR polymorphism carriers.
Biologically active methylated folate form. Absorbed as-is without MTHFR conversion. Preferred for individuals with MTHFR polymorphisms.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Likely safe | — |
| Pregnancy | Likely safe | — |
| Elderly | Likely safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)